1-8 of 8
Hong Xiao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Lower-Risk Myelodysplastic Syndromes Who Have Been Treated with Luspatercept

Ralph Boccia, Hong Xiao, Dimana Miteva, Min Che, Tao Gu, Ali McBride, Mrudula B. Glassberg, Aylin Yucel
Journal: Blood
Blood (2023) 142 (Supplement 1): 7411.
https://doi.org/10.1182/blood-2023-173360
Published: 2023
Journal Articles

Patient-Reported Outcomes (PRO) of Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent (ESA)-Naïve, Transfusion-Dependent (TD), Lower-Risk Myelodysplastic Syndromes (LR-MDS): Results from the Phase 3 COMMANDS Study

Esther Natalie Oliva, Uwe Platzbecker, Matteo Giovanni Della Porta, Guillermo Garcia-Manero, Valeria Santini, Pierre Fenaux, Jake Shortt, Rami S. Komrokji, Christopher Pelligra, Shien Guo, Jennifer Lord-Bessen, Hong Xiao, Aylin Yucel, Dimana Miteva, Shelonitda Rose, Sandra Kreitz, Mikkael A. Sekeres, Amer M. Zeidan
Journal: Blood
Blood (2023) 142 (Supplement 1): 4596.
https://doi.org/10.1182/blood-2023-174660
Published: 2023
Journal Articles

Clinical Characteristics, Genomic Profiling and Outcomes of Langerhans Cell Histiocytosis in Adults with Single System Multifocal Disease

Hong-Xiao Han, Long Chang, Min Lang, Lin He, Jian Li, Minghui Duan, Daobin Zhou, Xinxin Cao, Wen Gao
Journal: Blood
Blood (2023) 142 (Supplement 1): 1165.
https://doi.org/10.1182/blood-2023-178177
Published: 2023
Journal Articles

High Mutational Burden of Chromatin-Modifying Genes Defines a Relatively Indolent Subgroup of Plasma Cell Dyscrasias

Xuezhu Wang, Bing Qiao, Yanying Yu, Jian Xu, Liping Zuo, Jia Chen, Hao Cai, Hong-xiao Han, Xin-xin Cao, Chunyan Sun, Jian Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 12452–12453.
https://doi.org/10.1182/blood-2022-164477
Published: 2022
Journal Articles

Treatment Patterns and Outcomes in Lower-Risk, Non-Del(5q) Myelodysplastic Syndromes: Findings from a Global Real-World Medical Record Review Study

Maria Diez-Campelo, Aylin Yucel, Ravi K. Goyal, Rohan C. Parikh, Elizabeth Esterberg, Maria Jimenez, Martina Sluga-O'Callaghan, Dimana Miteva, Hong Xiao, Ulrich Germing
Journal: Blood
Blood (2022) 140 (Supplement 1): 13308–13309.
https://doi.org/10.1182/blood-2022-156411
Published: 2022
Journal Articles

Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes: Systematic Literature Review

Ralph V. Boccia, Sohan Deshpande, Caroline von Wilamowitz-Moellendorff, Renuka Raorane, Sven L. Klijn, Hong Xiao, Aylin Yucel
Journal: Blood
Blood (2022) 140 (Supplement 1): 12355–12356.
https://doi.org/10.1182/blood-2022-156783
Published: 2022
Journal Articles

Potent and Orally Bioavailable BCL6 PROTAC TM Degraders Demonstrate Efficacy in Pre-Clinical Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Sheryl M Gough, Dan Sherman, Lynn DeCarr, Sarah Eaton, Maja Milanovic, Mark Bookbinder, Jennifer Pizzano, Martha Altieri, John Corradi, Hong Xiao, Felipe Gallego, Leofal Soto, Ram Lingamaneni, Xin Chen, Wei Zhang, Gan Wang, Hanqing Dong, Deborah Chirnomas, Michael Berlin, Keith Hornberger, Lawrence Snyder, Ian Taylor
Journal: Blood
Blood (2021) 138 (Supplement 1): 2272.
https://doi.org/10.1182/blood-2021-149654
Published: 2021
Journal Articles

Chronic Myeloid Leukemia and BCR/ABL Signal Pathway Are Not Associated with AKT1 Pleckstrin Homology Domain( E17K ) Mutations.

Yanli He, Jine Zheng, MD, Yanjie Hu, Hong Xiao, Huiyu Li, Jun Liu, Xiaoqing Li, PhD, Wen Du, Xiangjun Chen, Yu Hu, Shiang Huang
Journal: Blood
Blood (2009) 114 (22): 4262.
https://doi.org/10.1182/blood.V114.22.4262.4262
Published: 2009